Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain

被引:73
作者
Chan, PKS [1 ]
Ng, HK
Hui, M
Cheng, AF
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
latency; nervous system; neuroinvasion; neuropathology; persistence; tropism;
D O I
10.1002/jmv.1015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The presence of human herpesvirus 6 (HHV-6) in brain tissues of 40 consecutive post-mortem cases was examined. For each case, autopsy samples were collected from the cerebellum, frontal, temporal, parietal and occipital lobes of both sides of the brain. HHV-6 DNA was detected by nested polymerase chain reaction and characterised into variants A and B. Overall, 97/400 (24.3%) samples were positive for HHV-6 DNA with 16 being variant A and 81 being variant B, but none of the samples harboured both variants. When analysed by patient, 34/40 (85%) had HHV-6 DNA detected in the brain. The viral DNA positivity did not show significant variation with gender and age. Four patients harboured variant A, 23 harboured variant B, and seven had both variants at different positions. The results indicate that both HHV-6A and HHV-6B are neurotropic and human brain may be another site for latency. HHV-6B was detected in brain tissues of a majority (75%) of the studied population and with a widespread distribution within the brain. Although the observed prevalence of HHV-6A in brain is lower (27.5%), in view of its lower seroprevalence, the neuroinvasive potential of variant A may be comparable to that of variant B. Although both variants are potential pathogens for the nervous system, the fact that they can exist, probably for most of the time, as commensals in human brain needs to be considered when interpreting their roles in neuropathology. J. Med. Virol. 64:42-46, 2001. (C) 2001 Wiley-Liss.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 37 条
[1]   UTILIZATION OF HUMAN HEMATOPOIETIC-CELL LINES FOR THE PROPAGATION AND CHARACTERIZATION OF HBLV (HUMAN HERPESVIRUS-6) [J].
ABLASHI, DV ;
LUSSO, P ;
HUNG, CL ;
SALAHUDDIN, SZ ;
JOSEPHS, SF ;
LLANA, T ;
KRAMARSKY, B ;
BIBERFELD, P ;
MARKHAM, PD ;
GALLO, RC .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :787-791
[2]   FATAL ENCEPHALITIS ENCEPHALOPATHY IN PRIMARY HUMAN HERPESVIRUS-6 INFECTION [J].
ASANO, Y ;
YOSHIKAWA, T ;
KAJITA, Y ;
OGURA, R ;
SUGA, S ;
YAZAKI, T ;
NAKASHIMA, T ;
YAMADA, A ;
KURATA, T .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (12) :1484-1485
[3]   ANTIGENIC AND GENETIC DIFFERENTIATION OF THE 2 PUTATIVE TYPES OF HUMAN HERPES VIRUS-6 [J].
AUBIN, JT ;
AGUT, H ;
COLLANDRE, H ;
YAMANISHI, K ;
CHANDRAN, B ;
MONTAGNIER, L ;
HURAUX, JM .
JOURNAL OF VIROLOGICAL METHODS, 1993, 41 (02) :223-234
[4]   Human herpesvirus six and multiple sclerosis [J].
Carrigan, DR ;
Knox, KK .
MULTIPLE SCLEROSIS, 1997, 3 (06) :390-394
[5]   NEUROINVASION AND PERSISTENCE OF HUMAN HERPESVIRUS-6 IN CHILDREN [J].
CASERTA, MT ;
HALL, CB ;
SCHNABEL, K ;
MCINTYRE, K ;
LONG, C ;
COSTANZO, M ;
DEWHURST, S ;
INSEL, R ;
EPSTEIN, LG .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1586-1589
[6]   PLAQUE-ASSOCIATED EXPRESSION OF HUMAN HERPESVIRUS-6 IN MULTIPLE-SCLEROSIS [J].
CHALLONER, PB ;
SMITH, KT ;
PARKER, JD ;
MACLEOD, DL ;
COULTER, SN ;
ROSE, TM ;
SCHULTZ, ER ;
BENNETT, JL ;
GARBER, RL ;
CHANG, M ;
SCHAD, PA ;
SEWART, PM ;
NOWINSKI, RC ;
BROWN, JP ;
BURMER, GC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7440-7444
[7]  
Chan PKS, 1999, J MED VIROL, V59, P491, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt
[8]  
491::AID-JMV11&gt
[9]  
3.0.CO
[10]  
2-1